3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Polycystic Ovary Syndrome
4
Obesity
4
Breast Neoplasms
4
Ovarian Diseases
2
Ovarian Cysts
2
Motor Activity
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Cardiovascular Diseases
2
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Overweight
1
Neoplasms
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Monoclonal Gammopathy of Undetermined Significance
1
Metabolic Syndrome
1
Intermittent Fasting
1
Inflammation
1
Growth Hormone-Secreting Pituitary Adenoma
1
Fibrosis
1
Feeding Behavior
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Carcinoma, Hepatocellular
1
Angina, Unstable
1
Interventions
Curcumin
2
Specimen Handling
1
Probiotics
1
Oxycodone
1
Music Therapy
1
Moxifloxacin
1
Morphine
1
Methadone
1
Glucose
1
Docosahexaenoic Acids
1
Diet, Plant-Based
1
Diet, Mediterranean
1
Ciprofloxacin
1
Amoxicillin-Potassium Clavulanate Combination
1
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Monoclonal Gammopathy of Undetermined Significance
×
Diet, Mediterranean
×
Clear all
NCT07446777
2026-05-01
FAST-M
University of Miami
Phase NA
Recruiting
120 enrolled